期刊文献+

NB-UVB联合退白汤治疗白癜风的临床研究 被引量:10

Clinical study on NB-UVB combined with Tuibai Decoction in the treatment of vitiligo
原文传递
导出
摘要 目的:探讨窄谱中波紫外线(NB-UVB)局部照射联合退白汤内服治疗白癜风的临床疗效和安全性。方法:将120例白癫风患者随机分为3组,每组40例,治疗组予NB-UVB局部照射,初始剂量为0.5J/cm2,2次/w,每次剂量递增10%~20%,至出现红斑时维持治疗,内服退白汤,2次/d;对照Ⅰ组单纯内服退白汤;对照Ⅱ组单纯使用NB-UVB局部照射,方法均同治疗组,3组均连续治疗12周,分别于治疗第4、8和12周时评价临床疗效。结果:治疗组、对照Ⅰ组、对照Ⅱ组治疗12周时的有效率分别为77.5%、55.0%和47.5%,治疗组与对照Ⅰ组、对照Ⅱ组比较差异均有统计学意义。治疗组皮损开始复色时间明显早于对照Ⅰ组、对照Ⅱ组,P<0.01。治疗组不良反应发生率为12.5%,对照Ⅰ组为7.5%,对照Ⅱ组为12.5%,3组比较,差异均无统计学意义。结论:NB-UVB局部照射联合退白汤内服治疗白癜风疗效确切,安全性好,值得皮肤科临床推广应用。 To investigate the clinical effect and safety of narrow-band ultraviolet B ( NB-UVB ) patial irradiation combined with Tuibai Decoction taken orally in the treatment of vitiligo. Methods :120 cases of vitiligo patients were randomly divided into 3 groups, 40 cases in each group, the treatment group treated with NB-UVB irradiation, the initial dose was 0.5J/cm2,2 times per week, each dose increasing 10%- 20%, and maintain the dose when erythema appeared, taken orally of Tuibai Decoction, 2 times per day. Control group I merely took Tuibai Decoction orally; Control group Ⅱ only use NB-UVB partial irradiation, methods were the same with the treatment group. 3 groups were treated for 12 weeks continuously, and the clinical effect were evaluated respectively in the treatment of 4, 8 and 12 weeks. Results: The effect ratios of treatment group, control group Ⅰ , and control group Ⅱ were 77.5%, 55% and 47.5% respectively after 12 weeks of treat- ment. The differences were statistically significant when treatment group compared with control group I and control group Ⅱ. ( P 〈 0.05or P 〈 0.01 ). Color-recovering starting time of treatment group was significantly earlier than control group I and control group Ⅱ, and the differ- ences were statistically significant ( P 〈 0.01 ). The incidence of adverse reaction of treatment group was 12.5%, 7.5% in control group I and 12.5% in control group Ⅱ , the difference was not statistically significant when the 3 groups compared with each other( P 〉 0.05 ). Conclusion: Clinical effect of NB-UVB partial irradiation combined with Tuibai Decoction taken orally in the treatment of vitiligo is definite , with good safety, worthy of clinical popularization and application in the department of dermatology.
出处 《中药药理与临床》 CAS CSCD 北大核心 2013年第2期187-189,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 南通市指令性社会发展科技计划项目(编号:S2009047)
关键词 退白汤 白癜风 NB-UVB 临床疗效 安全性 Tuibai Decoction vitiligo NB-UVB clinical effect safety
  • 相关文献

参考文献7

二级参考文献86

共引文献471

同被引文献102

  • 1欧阳恒,祝柏芳.紫铜消白方治疗白癜风的临床研究[J].中国中医药科技,1995,2(5):13-16. 被引量:38
  • 2汪京峡,段爱霞,张大军.白癜风患者血清中白介素及肿瘤坏死因子水平变化的研究[J].皮肤病与性病,2006,28(1):4-5. 被引量:16
  • 3陈鹏,蒋献.窄谱中波紫外线治疗皮肤病的作用机制[J].国际皮肤性病学杂志,2007,33(1):33-35. 被引量:26
  • 4张继玲,曹碧兰.白癜风免疫学说新进展[J].遵义医学院学报,2006,29(4):403-407. 被引量:8
  • 5郑晓萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.60-66.
  • 6Abu Tahir M, Pramod K, Ansari SH, et al. Current remedies for vitiligo [ J]. Autoimmun Rev ,2010,9 (7) :516 - 520.
  • 7Wang CQ, Cruz-Inigo AE ,Fuentes-Duculan J,et al. Thl7 ceils and acti- vated dendritic ceils are increased in vitiligo lesions [ J ]. PLoS One, 2011,6(4) :e 18907.
  • 8Rezaei N, Gavalas NG, Weetman AP, et al. Autoimmunity as an aetiologi- cal factor in vitiligo [ J]. J Eur Acad Dermatol Venereol,2007,21(7 ) : 865 - 876.
  • 9Guerra L, Dellambra E, Brescia S, et al. Vitiligo : pathogenetic hypothesesand targets for eurrenl therapies[ J]. Curr Drug Metab ,2010,11 (5) :451 - 467.
  • 10Kotobuki Y, Tanemura A, Yang L, et al. Dysregulation of melanocyte function by Th17-related cytokines:significance of Thl7 cell infiltration in autoimmune vitiligo vulgaris[ J ]. Pigment Cell Melanoma Res, 2012, 25(2) :219 -230.

引证文献10

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部